CAVEOLAE AND CAVEOLINS IN MUSCULAR DYSTROPHIES
- 2 Anni 1998/2000
- 103.291€ Totale Fondi
Descrizione non disponibile
Pubblicazioni Scientifiche
- 1999 JOURNAL OF BIOLOGICAL CHEMISTRY
Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C) - Retention of LGMD-1C caveolin-3 mutants within the Golgi complex
- 2000 JOURNAL OF BIOLOGICAL CHEMISTRY
Caveolin-3 directly interacts with the C-terminal tail of beta-dystroglycan - Identification of a central WW-like domain within caveolin family members
- 1999 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Early decrease of IIx myosin heavy chain transcripts in Duchenne muscular dystrophy
- 1999 FEBS LETTERS
Localization of the human caveolin-3 gene to the D3S18/D3S4163/D3S4539 locus (3p25), in close proximity to the human oxytocin receptor gene - Identification of the caveolin-3 gene as a candidate for deletion in 3p-syndrome
- 1999 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Increased number of caveolae and caveolin-3 overexpression in Duchenne muscular dystrophy
- 1998 AMERICAN JOURNAL OF HUMAN GENETICS
Molecular genetics of the caveolin gene family: Implications for human cancers, diabetes, Alzheimer disease, and muscular dystrophy
- 2000 JOURNAL OF BIOLOGICAL CHEMISTRY
Limb-girdle muscular dystrophy (LGMD-1C) mutants of caveolin-3 undergo ubiquitination and proteasomal degradation - Treatment with proteasomal inhibitors blocks the dominant negative effect of LGMD-1C mutants and rescues wild-type caveolin-3
- 2000 NEUROLOGY
Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia
- 2000 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AME
Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype
- 1999 CURRENT OPINION IN GENETICS & DEVELOPMENT
Muscular dystrophies: alterations in a limited number of cellular pathways?